A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease.
A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease. Clin Drug Investig. 2008; 28(5):291-303.